Lv2
120 积分 2021-07-06 加入
Safety and Lipid-Lowering Efficacy of Inclisiran Monotherapy in Patients Without ASCVD
54分钟前
待确认
GLP-1, Parkinson’s Disease, and Neuroprotection
7天前
已完结
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both
24天前
已完结
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia
24天前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
24天前
已完结
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
24天前
已完结
899-P: Study on the Efficacy and Safety of Henagliflozin Combined with Continuous Subcutaneous Insulin Infusion in the Treatment of Type 2 Diabetes—A Multicenter, Randomized, Open-Label, Controlled Study
1个月前
已关闭
Impact of PCSK9 Inhibitor Recaticimab on Hyperlipidemia and Plasma Glucose: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Study
2个月前
已关闭
PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study
2个月前
已完结
An evaluation of recaticimab for the treatment of hypercholesterolemia
2个月前
已完结
皖公网安备34019202002308
